Status:
COMPLETED
M-I/E for Preventing VAP in Post-neurosurgical Patients
Lead Sponsor:
Beijing Sanbo Brain Hospital
Conditions:
Ventilator Associated Pneumonia
Brain Injuries
Eligibility:
All Genders
18+ years
Brief Summary
Ventilator-associated pneumonia (VAP) is a common infection in critically ill patients, especially those with acute brain injuries, leading to increased mortality and longer ICU stays. The mechanical...
Eligibility Criteria
Inclusion
- Post-neurosurgical adult patients
- \>18years old
- Body mass index (BMI) \<35kg/m2)
- Receiving mechanical ventilation
- With arterial blood catheter for continuous pressure measurement and/or ventricular catheter drainage for ICP measurement (only for study one)
Exclusion
- ICP \> 22cmH2O or evidence of increased ICP
- Hemodynamically unstable (SBP\< 90 or \> 160 mmHg; DBP \< 50 or \> 110 mmHg, using cardiovascular medicine to maintain pressure, or known cardiac failure)
- Patients with lung trauma, emphysema, bronchopleural fistula or risk of pneumothorax
- History of mechanical ventilation and pneumonia within 6 months before ICU admission
Key Trial Info
Start Date :
March 4 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2025
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT06511986
Start Date
March 4 2024
End Date
March 15 2025
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Sanbo Brain Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100090